Besides, the results of analysis in the TCGA database indicated that LOXL2 expression was markedly increased in BLCA, GBMLGG, LIHC, LUAD, and UVM with higher clinical or pathological stages (Figure S1B). Here, LOXL2 is linked to bladder transitional cell carcinoma.